A major scientific challenge in neuroscience is the identification and characterization at molecular level of the cellular changes in various physiological conditions and pathological neurological disorders. Critical to the success of this endeavor is the development and implementation of new tools for rapid and sensitive protein identification and characterization of their post-translational modifications. High sensitivity of mass spectrometry has become an invaluable tool for such studies. The major goal of the proposed """"""""MINDS Mass Spectrometry Proteomics Core Facility for Neurosciences at MSSM"""""""" is to establish a core facility with dedicated personnel in supporting NINDS-funded neuroscience research programs, to expand and upgrade the capacity and sensitivity of our mass spectrometry facility, to apply state-of-the-art mass spectrometry technologies to critical protein and neuropeptide analysis involved in neuroscience and neurological disease research, and to enable and strengthen neuroscience research program at Mount Sinai.
The specific aims of this core facility are: (1) To provide rapid, cost-effective, and high-quality mass spectrometry proteomics service for NINDS and other neuroscience-oriented investigators at Mount Sinai and other NINDS-funded investigators in other institute in order to perform cutting-edge research in which new mass spectrometric technologies are used to solve important biochemical and biomedical problems. (2) To transfer newly developed mass spectrometry technology from my research laboratory to the NINDS Core Facility and expand the capacity and upgrade the sensitivity of mass spectrometry techniques for assisting NINDS-funded and other neuroscience-oriented investigators. (3) To educate NINDS-funded investigators, other neuroscience-oriented scientists, and their staffs on using mass spectrometry for protein analysis in neuroscience. (4) To stimulate new research initiatives and facilitate collaborations in neuroscience.
The proposed NINDS Mass Spectrometry Proteomics Center for Neurosciene at MSSM is to provide state of- the-art mass spectrometry technology support to NINDS-funded and other neuroscience-oriented researches. It will greatly facilitate researches aimed at understanding, diagnosis and treatment of neurological disorders, such as Parkinson's disease and Alzheimer's disease.
|Choi, Soon Gang; Wang, Qian; Jia, Jingjing et al. (2016) Characterization of Gonadotrope Secretoproteome Identifies Neurosecretory Protein VGF-derived Peptide Suppression of Follicle-stimulating Hormone Gene Expression. J Biol Chem 291:21322-21334|
|Fernandez, Marty A; Biette, Kelly M; Dolios, Georgia et al. (2016) Transmembrane Substrate Determinants for ?-Secretase Processing of APP CTF?. Biochemistry 55:5675-5688|
|Lim, Junghyun; Lachenmayer, M Lenard; Wu, Shuai et al. (2015) Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet 11:e1004987|
|Jahouh, Farid; Wang, Rong (2015) Simultaneous quantification of labeled (2)H5-glycerol, (13)C6-glucose, and endogenous D-glucose in mouse plasma using liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 407:8617-22|
|Aguilo, Francesca; Zhang, Fan; Sancho, Ana et al. (2015) Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming. Cell Stem Cell 17:689-704|
|DeBoer, Scott R; Dolios, Georgia; Wang, Rong et al. (2014) Differential release of ?-amyloid from dendrite- versus axon-targeted APP. J Neurosci 34:12313-27|
|Wang, Yuan; Kou, Yan; Wang, Xiaodong et al. (2014) Multifactorial comparative proteomic study of cytochrome P450 2E1 function in chronic alcohol administration. PLoS One 9:e92504|
|Li, Jing Jing; Dolios, Georgia; Wang, Rong et al. (2014) Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression. PLoS One 9:e90770|
|Zhang, Xulun; Hoey, Robert; Koide, Akiko et al. (2014) A synthetic antibody fragment targeting nicastrin affects assembly and trafficking of ?-secretase. J Biol Chem 289:34851-61|
|Steele, J W; Lachenmayer, M L; Ju, S et al. (2013) Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Mol Psychiatry 18:889-97|
Showing the most recent 10 out of 16 publications